Appco Pharma LLC recalls Venlafaxine Extended-Release Tablets
- Published
- 29 Jan 2025
- Units affected
- 1380 bottles
- Agency
- FDA
- Country
- United States
The hazard
Failed Tablet/Capsule Specifications: Missing tab ID on either side of the tablet
Classification: Class III — this product is unlikely to cause health problems but breaks FDA rules (for example labeling).
What to do
Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.
- Check the lot number on the box or bottle.
- Talk to your pharmacist or doctor before stopping any prescribed medicine.
- Return the product to the pharmacy for safe disposal.
Product details
Venlafaxine Extended-Release Tablets, 150mg, Rx only, 90 Tablets, Manufactured by Appco Pharma. LLC, NDC 43598-943-90.
- Brand / company
- Appco Pharma LLC
- Codes / lots
- Lot #: 2402101UR, Exp 02/28/2027
- Distribution
- Nationwide USA.
- Recall status
- Completed
Source: U.S. Food and Drug Administration, published 29 Jan 2025. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.